PURPOSE OF THIS STUDY
The purpose of this study is to compare two non-invasive neurostimulation techniques (ECT and MST) in the treatment of schizophrenia and schizoaffective disorder.
WHO CAN PARTICIPATE
This study is open to adults aged 19 or above who have been diagnosed with schizophrenia or schizoaffective disorder and have not responded to at least two medications. Participants must be comfortable receiving brain stimulation treatments under general anaesthesia.
WHAT IS INVOLVED
Participants will visit the study site two days per week for eight weeks to receive neurostimulation treatment, with visits lasting around two hours including preparation and recovery. As treatment will require general anesthesia, participants will need to arrange for a ride after each treatment. Participants will be asked to complete clinical assessments, questionnaires and cognitive assessments before and after the treatment.
This study also involves regular monitoring of symptoms and one follow-up visit six months after the final treatment.
OTHER DETAILS
- Study Time / Duration: Ongoing
- Study Location: Detwiller Pavilion, UBC Hospital, 2255 Wesbrook Mall, Vancouver
- Principal Investigator: Dr Fidel Vila-Rodriguez, Director, Non-Invasive Neurostimulation Therapies Laboratory and Interventional Brain Medicine Program Research Investigator, VCH Research Institute
CONTACT INFORMATION
Anabelle McPherson, Study Coordinator
Phone: 604-827-1761
Email: ninet.lab@ubc.ca